Hypothesis for a systems connectivity model of Autism Spectrum Disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability.

Autism Spectrum Disorders are neurodevelopmental disorders with symptoms that include cognitive impairments, stereotyped behaviors, and impairments in social skills. The dramatic increase in incidence of autism in recent years has created an increased need to find effective treatments. This paper proposes a hypothesis for a systems model of the connections between Autism Spectrum Disorder pathogenesis routes observed in recent studies. A combination treatment option is proposed to combat multiple pathogenesis mechanisms at once. Autism has been cited as being linked to gastrointestinal symptoms and is thought to be caused by a combination of genetic predisposition and environmental factors. Neuroinflammation as a result of increased gastrointestinal permeability has been noted as being a likely cause of Autism Spectrum Disorders, with possible primary causes stemming from abnormal intestinal bacteria and/or sulfur metabolic deficiencies. Our pathogenesis model proposes a circular relationship: oxidative stress and sulfur metabolic deficiencies could cause changes in colonic bacterial composition; and environmental bacterial contaminants could lead to elevated oxidative stress in individuals. It would thus be a self-perpetuating process where treatment options with single targets would have short-lived effects. It is believed that bacterial toxins, oxidative stress and dietary allergens such as gluten could all lead to increased epithelial permeability. Therefore, we propose a combination treatment to combat intestinal permeability, abnormal bacteria and/or bacterial overgrowth, and sulfur metabolic deficiencies. It is our hope that the proposed model will inspire new studies in finding effective treatments for individuals with Autism Spectrum Disorders. We suggest possible future studies that may lend more credibility to the proposed model.

[1]  Ronald H. Zielke,et al.  Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Fasano Leaky Gut and Autoimmune Diseases , 2012, Clinical Reviews in Allergy & Immunology.

[3]  Cynthia L Sears,et al.  A dynamic partnership: celebrating our gut flora. , 2005, Anaerobe.

[4]  C P Buchanan,et al.  Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism , 2000, Journal of child neurology.

[5]  S. Finegold,et al.  Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children , 2004, Applied and Environmental Microbiology.

[6]  Macfarlane,et al.  Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteria , 1998, Journal of applied microbiology.

[7]  Geociênicias Encyclopedia of Earth , 2013 .

[8]  J. Golding,et al.  The early stool patterns of young children with autistic spectrum disorder , 2009, Archives of Disease in Childhood.

[9]  W. Lipkin,et al.  Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances , 2011, PloS one.

[10]  T. Not,et al.  Ages of celiac disease: from changing environment to improved diagnostics. , 2011, World journal of gastroenterology.

[11]  Haroun Shah,et al.  Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Bartlett,et al.  Clinical recognition and diagnosis of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Finegold,et al.  Microbiology of regressive autism. , 2012, Anaerobe.

[14]  S. Finegold Therapy and epidemiology of autism--clostridial spores as key elements. , 2008, Medical hypotheses.

[15]  D. Cain,et al.  Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder , 2011, Behavioural Brain Research.

[16]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[17]  C. Mackay,et al.  Commensal flora and the regulation of inflammatory and autoimmune responses. , 2011, Seminars in Immunology.

[18]  Meei-Yn Lin,et al.  Antioxidative Effect of Intestinal Bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356 , 2000, Digestive Diseases and Sciences.

[19]  James B. Adams,et al.  Gastrointestinal flora and gastrointestinal status in children with autism -- comparisons to typical children and correlation with autism severity , 2011, BMC gastroenterology.

[20]  Maurizio Elia,et al.  Sulphation deficit in “low-functioning” autistic children: a pilot study , 1999, Biological Psychiatry.

[21]  W. Barbaresi,et al.  Incidence of Gastrointestinal Symptoms in Children : A Population-Based Study , 2009 .

[22]  J. Neu,et al.  Tight junctions, leaky intestines, and pediatric diseases , 2005, Acta paediatrica.

[23]  Janet K. Kern,et al.  A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.

[24]  M. Angley,et al.  A review of candidate urinary biomarkers for autism spectrum disorder , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[25]  K. Alysandratos,et al.  Brief Report: “Allergic Symptoms” in Children with Autism Spectrum Disorders. More than Meets the Eye? , 2011, Journal of autism and developmental disorders.

[26]  W. Barbaresi,et al.  Incidence of Gastrointestinal Symptoms in Children With Autism: A Population-Based Study , 2009, Pediatrics.

[27]  G. Macfarlane,et al.  Dissimilatory amino Acid metabolism in human colonic bacteria. , 1997, Anaerobe.

[28]  Eunseog Youn,et al.  Pyrosequencing study of fecal microflora of autistic and control children. , 2010, Anaerobe.

[29]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[30]  J. Meddings,et al.  The measurement and clinical significance of intestinal permeability , 2008, Current gastroenterology reports.

[31]  K. Aktories,et al.  Clostridial Rho-inhibiting protein toxins. , 2005, Current topics in microbiology and immunology.

[32]  Aletta D Kraneveld,et al.  Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. , 2011, European journal of pharmacology.

[33]  G. Macfarlane,et al.  Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. , 1993, Gut.

[34]  M. Peppelenbosch,et al.  Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. , 2010, Biochimica et biophysica acta.

[35]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[36]  Rustam I. Aminov,et al.  Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota , 2008, PloS one.

[37]  Anne L McCartney,et al.  Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. , 2005, Journal of medical microbiology.

[38]  J. Jansson,et al.  Molecular analysis of the gut microbiota of identical twins with Crohn's disease , 2008, The ISME Journal.

[39]  J. Baio Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.

[40]  S. Finegold Desulfovibrio species are potentially important in regressive autism. , 2011, Medical hypotheses.

[41]  E. Fernell,et al.  No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide , 2007, Acta paediatrica.